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Using g-ray irradiation, a pair of virulent (RP-9) and attenuated (RP-2ms) variants of Japanese encephalitis virus (JEV)
were generated from a Taiwanese isolate, NT109. The two variants differed in plaque morphology, virus adsorption, and
growth properties in BHK-21 cells: (i) RP-2ms produced smaller plaques than RP-9; (ii) RP-2ms adsorbed less efficiently to
host cells but yielded a higher virus titer (burst size); and (iii) RP-2ms virions were mostly accumulated intracellularly,
whereas RP-9 was released extracellularly. In addition, in an in vitro binding assay, the envelope (E) protein of RP-9, but
not that of RP-2ms, bound specifically to a cellular protein of 57-kDa derived from BHK-21 cells. When injected into mice
intracerebrally, RP-2ms was much less virulent than RP-9, with 50% lethal doses of 107 and 0.4 plaque forming units,
respectively. Moreover, when inoculated intraperitoneally, their organ tropism differed in that the main target organ for RP-
2ms was liver, whereas that for RP-9 was brain. These results suggest that RP-2ms was less neurovirulent and less
neuroinvasive from peripheral routes. Molecular analysis of the virus structural proteins detected only two differences
between RP-9 and RP-2ms: one in E protein, Glu-138 in RP-9 and Lys-138 in RP-2ms, and the other in prM, Tyr-43 in RP-9
and His-43 in RP-2ms. Since the N-terminal 92 amino acids of prM are cleaved and not present in mature JEV virions, the
single-amino-acid change of the E protein at position 138 may account for the difference between the mutants in the in
vitro binding assay. Such mutation in E protein, or perhaps in conjunction with the prM mutation, may be responsible, in
part, for the phenotypic differences observed in vitro and in vivo between the two mutants. q 1996 Academic Press, Inc.
INTRODUCTION ral (NS) proteins. Shortly before release from the cell, the
N-terminal of prM is proteolytically removed by a cellular
Japanese encephalitis virus (JEV) is a mosquito-borne and/or viral protease, leaving a membrane (M) protein of
flavivirus and causes an acute meningomyeloencepha- about 7 kDa in the mature virions (reviewed in Chambers
litis in humans. Like other arthropod-borne flaviviruses, et al., 1990).
JEV infection involves complex relationships among in- In human, the primary sites for JEV multiplication are
sect vectors, vertebrate reservoirs, human subjects, and thought to be either in myeloid and lymphoid cells or in
environmental factors (Chamberlain, 1980). In the natural vascular endothelial cells (Mathur et al., 1988). Yet, the
life cycle of JEV, human is the dead-end host, while other viremic phase in the JEV-infected human subject does
vertebrates, such as swine, may serve as an amplifying not occur or is too short to be detected, and it is unclear
reservoir for the maintenance of JEV (Chambers et al., whether JEV employs the neuronal spread to lead virus
1990). Among the medically important flaviviruses, JEV from the peripheral to the central nervous system. Al-
infection has the highest mortality rate with more than though the exact molecular basis of JEV pathogenesis
10,000 deaths worldwide annually, and remains one of in causing encephalitis is largely unknown, the fact that
the major public health problems in several parts of Asia the neuroinvasiveness of JEV varies from strain to strain
(Burke and Leake, 1988; Vaughn and Hoke, 1992). (Igarashi, 1994) indicates how JEV multiplication in the
JEV contains a single-stranded, positive-sense RNA of central nervous system depends essentially on the ability
approximately 11 kilobases in length, which has a single of the virus to penetrate the blood–brain barrier and to
open reading frame encoding a polyprotein. After transla- infect nerve cells. Conceivably, tissue and cell tropism
tion, the polyprotein is proteolytically processed into exhibited by a given virus reflects the presence of spe-
three structural proteins, including capsid, membrane cific interactions between the receptor(s) on the host
precursor (prM), and envelope (E), and seven nonstructu- cell surface and the exterior molecule(s) on the virions.
Similar to the mechanism operating for other enveloped
animal viruses, JEV is believed to utilize receptor-medi-1 To whom correspondence and reprint requests should be
ated endocytosis for the initiation of infection (Chambersaddressed. Fax: (886)-2-672-9820; E-mail address: lkchen@ndmc1.
ndmctsgh.edu.tw. et al., 1990). No cellular molecule has thus far been iden-
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tified as a receptor for JEV, whereas its counterpart, a acids, L-glutamine, and antibiotics. BHK-21 cells were
used for virus plaque assay.surface protein on virions, has been suggested to be the
E glycoprotein because E, but not other JEV structural
Generation of JEV mutant strains by g-ray irradiationproteins, is the major target for neutralizing antibodies
(Heinz, 1986). NT109 [1 1 104 plaque forming units (PFU)] was ex-
The monomer of E protein consists of approximately posed to g rays generated from a 137Cs irradiator (Mark I
500 amino acid residues, which normally form dimers on Model 30, J. L. Sphepherd Co.), and the resulting samples
the surface of mature virions at physiological pH (Heinz were plaqued on BHK-21 cells. Virus clones of various
et al., 1991). However, when exposed to acidic pH (below plaque sizes were individually plaque-purified and ampli-
6.5), dimers of E proteins undergo an irreversible confor- fied on BHK-21 cells. One large-plaque clone, called RP-
mational change, rearranging themselves into trimers 9, and a small-plaque clone, named RP-2, were selected
(Allison et al., 1995), which is presumably critical for the for further characterization. These two viruses were in-
fusion process between the viral envelope and the endo- jected intracerebrally (ic) into BALB/c mice, and viruses
somal membrane within the infected cells. Biologically, from the brains of infected mice were further plaque-
the E protein is the major structural protein of flaviviral purified on BHK-21 cells. Both large- and small-plaque
virions, which induces protective immunity in the infected viruses were generated from RP-2, whereas RP-9 gener-
hosts and mediates the virus–receptor interaction after ated uniformly large plaques. A virus clone, named RP-
virus attachment to the surface of host cells (Brinton, 2ms, was isolated from a small plaque of RP-2 virus, and
1986). Hence, E protein of JEV most likely plays a crucial it maintained uniform small-plaque size after reinjection
role in viral pathogenesis by determining the cellular sus- ic into BALB/c mice. Throughout this study, viruses of
ceptibility and organ tropism of the virus (Gollins and passage 5 or 6 in BHK-21 cells were used.
Porterfield, 1984; Heinz, 1986). Indeed, a number of ex-
perimental data have demonstrated that the changes of E Viral one-step growth curve
protein altered the biological properties of JEV in several
BHK-21 cells (2 1 106) were infected with viruses at aaspects; for instances, mutations in E protein of JEV influ-
multiplicity of infection (m.o.i.) of 5. After 1 hr of adsorptionenced virus entry into cultured cells and virulence in mice
at 377, the unbound virus particles were removed from(Hasegawa et al., 1992), were responsible for the loss of
cells by three washes with phosphate-buffered salineviral neuroinvasiveness in mice (Cecilia and Gould,
(PBS), and the infected cells were grown in RPMI medium1991), and were likely the molecular basis of virus attenu-
supplemented with 2% FBS at 377. At different time pointsation (Nitayaphan et al., 1990; Aihara et al., 1991; Ni et
postinfection (p.i.), the culture supernatants of infectedal., 1994, 1995; Sumiyoshi et al., 1995).
cells were collected and clarified by centrifugation, andTo study the neurovirulence and organ tropism of JEV
the virus titers in supernatants were determined byin mice, we have been interested in generating avirulent
plaque assay on BHK-21 cells. The cell-associated vi-mutants from local virus isolates in Taiwan. In this study,
ruses were harvested by subjecting infected cell mono-we characterized a pair of virulent and avirulent mutants
layers to three cycles of freezing and thawing. After addi-derived from a local JEV isolate after g-irradiation. Our
tion of appropriate amounts of media, virus particles re-results showed that, in vitro, the mutants differed in
leased in the supernatants were determined by plaqueplaque morphology, growth property, and adsorption be-
assay. The total virus titers were measured as the sumshavior when cultured on BHK-21 cells; in vivo, they varied
of virus titers in both the supernatants and the cell ly-in their neurovirulence and organ tropism in mice. To
sates. The burst size (PFU/cell) of viruses was deter-analyze the molecular differences between the mutants,
mined as the total numbers (PFU) of viable viruses di-we further compared their structural proteins in an at-
vided by the number of infected cells.tempt to elucidate the mechanisms involved in viral viru-
lence and organ tropism.
Viral adsorption assay
The amounts of viruses adsorbed on the surface ofMATERIALS AND METHODS
cells were determined by the method described pre-
Viruses and cells
viously (Asanaka and Lai, 1993). Briefly, BHK-21 cells
cultured in 60-mm dishes were adsorbed with 1.5 1 107A Taiwanese JEV strain, NT109, isolated from infected
mosquitoes Cx. tritaeniorhynchus in 1985 (kindly pro- PFU of viruses (m.o.i. 5) at 47 for various lengths of time.
To remove unbound viruses, cells in 60-mm dishes werevided by the National Institute of Preventive Medicine,
Taiwan, ROC), was used in this study to generate attenu- washed extensively three times with 3 ml of cold PBS
containing 0.5% bovine serum albumin and 0.05% Tweenated mutants. All viruses were propagated in BHK-21
cells or C6/36 cells of Aedes albopictus (Igarashi, 1978), 20. The cells were harvested from 60-mm dishes with
cell scrapers, and the adsorbed viruses on cells wereusing RPMI 1640 medium containing 5% heat-inactivated
fetal bovine serum (FBS) (Gibco), nonessential amino released by passing the cells through 27-gauge needles
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three times. After centrifugation, the supernatants con- each injection, we used 27-gauge one-stop needles (Top
Injection Needle, Tokyo, Japan). The mortality of infectedtaining viruses were plaque-assayed on BHK-21 cells to
determine the amounts of adsorbed virus. An alternative mice was monitored daily for 3 weeks.
approach was to determine the reduction of virus titer in
Determination of virus replication in mouse brainsthe inoculum after adsorption. For this purpose, BHK-21
cells cultured in 60-mm dishes were incubated with 1.5 To determine the replication ability of RP9 and RP2-1 107 PFU of viruses at 47 for various periods of times, ms in mouse brains, the tissues were obtained daily from
and the amounts of unbound viruses remaining in the the 4-week-old female ICR mice inoculated ic with 104
culture supernatants were determined by plaque assay PFU of viruses. The brain tissues were removed from
on BHK-21 cells. Percentage of reduction of virus titer each mouse and frozen immediately at 0707 until further
was expressed as follows: [10 (virus titer in supernatant use. To extract viruses, the frozen tissues were first
at indicated time point/virus titer in supernatant at Time thawed at 257 and then homogenized to make cell sus-
0 min)] 1 100. pensions; the resulting suspensions were subjected to
another round of freezing and thawing and diluted with
Cross-linking and immunoprecipitation PBS to make 20% (w/v) suspensions. After centrifugation
to clarify cell debris from suspensions, the supernatantsBHK-21 cell monolayers were grown and labeled as
containing viruses were stored at 0707 until used fordescribed previously (Carbone et al., 1993). After starva-
plaque assay on BHK-21 cells.tion in methionine-free RPMI 1640 for 1 hr, 50 mCi of
[35S]methionine (Amersham) in 2% dialyzed FCS medium
Organ distribution of viruses in infected micewas added and cells were incubated for 4 hr at 377.
The cross-linking reaction was performed according to Groups of 4-week-old female ICR mice were intraperi-
published procedures (Greenfield et al., 1990) with some toneally (ip) infected with 1 1 105 PFU of either RP-9 or
modifications. Briefly, virus was adsorbed onto the 35S- RP-2ms, and two of the infected mice were sacrificed
labeled cells at 47 for 1 hr, and the cells were then daily for the collections of sera and tissues. To obtain
washed twice with PBS to remove unbound viruses. The viruses from sera, the blood samples were diluted with
virus–cell complex was oxidized by 10 mM sodium met- an equal volume of PBS and centrifuged immediately
aperiodate (NaIO4) in buffer solution containing 0.1 M after being removed from the infected mice. To examine
sodium acetate (NaOAc), pH 5.5, for 20 min at 47 in the the distribution of viruses, different organs were individu-
dark. After washing with 0.1 M sodium acetate buffer, ally collected and processed to make tissue suspensions
3-(2-pyridyldithio)propionyl hydrazide (Pierce, Rockford) as described above. All of the samples containing vi-
was added to a final concentration of 5 mM, and the ruses were stored at 0707 until used for plaque assay
mixture was incubated with constant agitation for 2 hr at on BHK-21 cells.
room temperature. The resulting cells were rinsed with
PBS and lysed by a lysis buffer containing 1% Nonidet- RT-PCR and sequencing
P40, 0.1% sodium dodecyl sulfate (SDS), 150 mM NaCl,
The cDNAs of JEV mutants were generated by RT-PCR
50 mM Tris–HCl, pH 7.5, 150 mM NaCl, and 1 mM EDTA.
from viral RNAs and then sequenced according to the
Cell lysates were immunoprecipitated with anti-E, non-
published methods (Chomczynski and Sacchi, 1987).
neutralizing antibodies (unpublished data). After being
Briefly, the supernatants of JEV-infected cells containing
captured by staphylococcal protein A-coated beads (Pha-
viruses were incubated with lysis buffer (4 M guanidine
rmacia, Piscatanay, NJ), the precipitates were washed
thiocyanate, 50 mM Tris, pH 8.5, 10 mM EDTA, 0.5%
and boiled in the sample buffer containing 2-mercapto-
sarcosyl) for 15 min at 47, and the resulting mixtures were
ethanol. These immunoprecipitated proteins were sepa-
extracted twice with an equal volume of acid phenol/
rated by 10% SDS–polyacrylamide gel electrophoresis
chloroform. The RNA in the aqueous phase was precipi-
(PAGE) and the gels were dried and exposed to Kodak
tated by isopropanol. The primer sets flanking the JEV
X-ray film. In the binding-inhibition experiments, before
structural proteins used in RT-PCR were designed based
adsorbing onto BHK-21 cells, the RP-9 was preincubated
on the published JEV sequences (Sumiyoshi et al., 1987).
with a monoclonal antibody Na47-2, a neutralizing anti-
Purified RNA was reverse-transcribed into first-strand
body (unpublished data).
cDNA using 200 units of Moloney murine leukemia viral
reverse transcriptase (Bethesda Research Laboratories).Viral neurovirulence tests in mice
The first-strand cDNAs were PCR-amplified for 35 cycles
and each cycle consisted of 947 for 30 sec, 557 for 30The virulence of JEV mutants was determined by ic
injection of viruses into 3- to 4-week-old female BALB/c sec, and 727 for 30 sec. The resulting RT-PCR products
were then cloned into the TA-tailed pBluescript (Stra-mice. Thirty microliters of PBS containing various doses
of either RP-2ms or RP-9 were injected into the right tagene) vector generated by the published method
(Marchuk et al., 1991). The plasmids containing the JEVhemisphere of mouse brains. To ensure the depth of
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FIG. 1. Plaque morphology of parental JEV strain NT109 and its derivatives, RP-9 and RP-2ms, on BHK-21 cells. The infected cells were stained
by crystal violet at 4 days p.i.
inserts were purified by Wizard Minipreps DNA purifica- maintained the plateau until 48 hr p.i. Small-plaque RP-
tion system (Promega), and the inserts were sequenced 2ms replicated to higher titers than did large-plaque RP-
by Sequenase Version 2.0 DNA sequencing kit (United 9, especially after 20 hr p.i. At 36 hr p.i., the burst size
States Biochemical) following the manufacturer’s instruc- of RP-2ms was 17-fold (450 versus 26 PFU/cell) higher
tion. Five independent cDNA clones derived from one than that of RP9. Interestingly, during the 50-hr infection
such RT-PCR amplification were used to determine the period, the majority of infectious virions from the RP-9-
sequence within the region, and whenever the se- infected cells were released into the extracellular fraction
quences obtained from the above method were found to (Fig. 2A). In contrast, as high as 108 PFU of RP-2ms were
be different among two mutants (RP-9 and RP-2ms) and detected in both the intra- and the extracellular fractions
their parental strain NT109, direct sequencing using the after about 24 hr of incubation (Fig. 2B). In addition, when
above RT-PCR products as templates was performed as virus titers were measured in culture supernatants at
described previously (Chen et al., 1996) to further verify early time points after infection (4 to 12 hr p.i.), approxi-
the mutations. mately 100-fold fewer RP-2ms virions than RP-9 were
released (Fig. 2). However, at 24 hr p.i., RP-2ms produced
approximately 100-fold more intracellular infectious viri-RESULTS
ons than did RP-9 (Fig. 2). Cell-associated, intracellular
Characterization of the growth properties of JEV virions constituted the majority of the total RP-2ms virus
mutants with different plaque sizes on BHK-21 cells titers early in infection until 28 hr p.i.; afterward, the extra-
cellular virus titers exceeded the intracellular titers, prob-JEV NT109, a wild-type strain derived from a local isolate,
ably due to the lysis of infected cells (Fig. 2B). Similarexhibited heterogeneous plaque sizes when cultured on
experiments using neuronal N18 and NT2 cells were alsoBHK-21 cells (Fig. 1). After g-ray irradiation, virus clones
carried out and similar results were observed; specifi-with different plaque sizes were individually plaque-purified
cally, RP-2ms was cell-associated and intracellular (dataand amplified on BHK-21 cells. The identity of these virus
not shown). These results indicate the difference be-clones was confirmed by serology with JEV-specific anti-
tween these two mutants in viral replication and matura-bodies and RT-PCR with JEV-specific primers (data not
tion in BHK-21 cells and in neuronal cells. The cell asso-shown). Among them, RP-9 maintained homogeneously
ciation of RP-2ms may limit the spread of virus to neigh-large plaques, whereas RP-2ms steadily showed small
boring cells, thus explaining the small plaque size ofplaques on BHK-21 cells for repeated passages (Fig. 1).
RP-2ms.Similar plaque morphology of these two variants was also
We next examined whether the ability of virus to ad-observed on a mouse neuroblastoma cell line N18 and a
sorb to cells could account for the difference in theirhuman neuronal progenitor cell line NT2 (data not shown).
growth properties. To inhibit or retard the process ofLarge-plaque RP-9 and small-plaque RP-2ms were used
viral penetration into cells, viral adsorption assays werethroughout the following studies.
performed at 47 (see Materials and Methods). As shownThe growth rate of these two variants in BHK-21 cells
in Fig. 3A, RP-9 exhibited a higher adsorption rate thanwas analyzed by one-step growth curves. For both vi-
ruses, the viral titer reached the peak at 28 hr p.i. and did RP-2ms; after 2-hr incubation, approximately fivefold
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FIG. 2. One-step growth curves of RP-9 and RP-2ms in BHK-21 cells. BHK-21 cells were infected with (A) RP-9 or (B) RP-2ms at m.o.i. of 5 and
cultured for various time periods. Virus titers in the culture supernatants and the cell lysates of infected cells at indicated time points were determined
by plaque assay on BHK-21 cells. The total virus titers were the sum of virus titers in supernatants and cell lysates.
more RP-9 was adsorbed than RP-2ms onto BHK-21 cells The results from both experiments may account for the
slow spread of RP-2ms to neighboring cells, resulting in(Fig. 3A). RP-9 could saturate the adsorption to BHK-21
cells after a 2-hr incubation, whereas RP-2ms required smaller plaque size seen in cell cultures.
more than 4 hr to reach the plateau (data not shown). In
a parallel experiment, we also determined the amounts Binding assay of JEV onto BHK-21 cells by cross-
of unbound viruses remaining in culture supernatants linking and immunoprecipitation
after adsorption to BHK-21 cells (see Materials and Meth-
ods); the results revealed that the amounts of unbound To analyze the basis for the differences between RP-
9 and RP-2ms in viral adsorption, we performed an inRP-9 left in supernatants were less than those of un-
bound RP-2ms (Fig. 3B), illustrating that RP-9 could ad- vitro binding assay to identify the cellular protein(s) in-
volved in this binding. JEV were first allowed to bind tosorb to BHK-21 cells more efficiently than did RP-2ms.
FIG. 3. (A) Adsorption rate of RP-9 and RP-2ms on BHK-21 cells. BHK-21 cells in 60-mm dishes were incubated with 1.5 1 107 PFU of either RP-
2ms or RP-9 at 47 for various periods of times, and the cells were extensively washed and disrupted. Virus titers from the resulting mixtures were
determined by plaque assay to determine the amounts of adsorbed virus. (B) Percentage of removal of infectivity from the inoculum after adsorption
to BHK-21 cells. BHK-21 cells cultured in 60-mm dishes were adsorbed with 1.5 1 107 PFU of viruses at 47 for various periods of times, and the
amounts of unbound viruses remaining in the culture supernatants were determined by plaque assay on BHK-21 cells. The percentages of the
reductions of virus titers were determined as described under Materials and Methods.
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or RP2-ms, and the mortality of the infected mice was moni-
tored daily for 3 weeks (Table 1). A striking difference in
virulence between the two viruses was observed. The LD50
of RP2-ms was greater than 107 PFU, whereas the LD50 of
RP-9 was only 0.4 PFU. As few as 100 PFU of RP-9 was
sufficient to kill all of the infected mice. In contrast, RP-2ms
appeared to be highly attenuated since even 107 PFU did
not kill any mice. In addition, RP-2ms did not produce any
noticeable symptoms in infected mice. The same experi-
ments were also performed in ICR and C3H mice, and
similar results were observed (data not shown). Therefore,
the differences in neurovirulence between RP9 and RP2-
ms was not restricted to a certain mouse strain. Consistent
with previous observations (Eckels et al., 1988; Sumiyoshi
et al., 1995), large-plaque RP-9 appeared to be more virulent
than small-plaque RP-2ms.FIG. 4. (A) Binding assay of JEV mutants onto BHK-21 cells by cross-
To ascertain whether the neurovirulence of virus mu-linking and immunoprecipitation. [35S]Methionine-labeled BHK-21 cells
were adsorbed and cross-linked with RP-2ms (lane 2), RP-9 (lane 3), tants was linked to their replication abilities in mouse
or mock (lane 1), and the cell lysates were immunoprecipitated by a brains, we determined the virus titers in brain tissues
mixture of nonneutralizing anti-E antibodies. Immunocomplexes were obtained daily from the mice that had been ic inoculated
separated on 10% SDS–PAGE under reducing condition. The cellular
with 104 PFU/mouse of either virus. RP-9 replicated to aprotein of 57-kDa (p57) is indicated by an arrow. Protein markers in kDa
peak titer of 107 PFU at Day 4 p.i., which lasted until 6are provided on the left. (B) Inhibition of virus binding by a neutralizing
antibody. RP-9 was preincubated with (lane 2) or without (lane 1) Na47- days p.i. when all mice died (Fig. 5). In contrast, RP-2ms
2 prior to adsorbtion onto 35S-labeled BHK-21 cells. The remaining yielded a virus titer of approximately 2log10 lower than
procedures were as described in (A). that of RP-9 at Day 5 p.i.; after Day 7 p.i., RP-2ms was
cleared from the infected mice. No neurological symp-
toms were noticed in the RP-2ms-infected mice. These[35S]methionine-labeled BHK-21 cells and fixed by chemi-
data indicated that the lack of neurovirulence of RP-2mscal cross-linking. After lysis of virus–cell mixtures, the
was not due to the failure of the virus to replicate in thelysates were immunoprecipitated by antibodies against
brain, although the virus yield was lower.the JEV E protein, which is expected to bind to cell sur-
face molecules, and analyzed by electrophoresis on a Study of organ tropism for RP-9 and RP-2ms after
reducing SDS–PAGE. The profiles of surface molecules intraperitoneal injection
from BHK-21 cells captured by this measure are shown
To study the ability of viruses to spread in differentin Fig. 4. A cellular molecule of approximately 57 kDa
tissues, the viruses were ip injected into mice. The serawas detected with RP-9 virus but not with RP-2ms (Fig.
4A, lanes 1 to 3). When the viruses were preincubated
TABLE 1with an anti-JEV neutralizing antibody, Na47-2 (Fig. 4B),
the 57-kDa protein was not detected, indicating the spec- Neurovirulence of RP-2ms and RP-9 in Micea
ificity of this interaction. This 57-kDa molecule was likely
No. of surviving animalsa membrane protein derived from BHK-21 cells because
Challenge doses No. of inoculated animalsthe cross-linking experiment was performed under the
(pfu/mouse) (surviving rate)
condition in which the internalization of virus was largely
inhibited. These data suggest that the difference(s) in the RP-2ms
growth properties between the two mutants may be due 107 8/8 (100%)
106 8/8 (100%)to differences in virus attachment at the early stage of
105 8/8 (100%)infection. Since the viral E protein is responsible for viral
104 8/8 (100%)
attachment, it is likely that the E protein of these two 103 8/8 (100%)
viruses differs. RP-9
103 0/8 (0%)
102 0/8 (0%)Virulence and replication studies of JEV mutants in
101 1/8 (12.5%)mice
100 2/8 (25%)
1001 6/8 (75%)To study viral virulence, we first determined the 50%-
lethal dose (LD50, the virus dose which can kill 50% of the a Different doses of RP-2ms or RP-9 in 30 ml PBS were injected into
mice) of virus mutants in infected mice. Groups of eight the right hemisphere of the brains of 3-week-old BALB/c mice. The
mortality of mice was monitored daily for 3 weeks.mice were ic inoculated with various doses of either RP9
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TABLE 2
Amino Acid Differences in the Structural Proteins among Parent
and Mutant JEV Strains
prM/aa 43 E/aa 138
NT109 Tyr Glu
RP-9 Tyr Glu
RP-2ms His Lys
replication in the liver. No virus was detected in the brain.
The fact that RP-2ms replicated in the brain by ic inocula-
tion (see above) but failed to do so when peripherally
FIG. 5. The replication of JEV mutants in mouse brain tissues. Three- inoculated indicated the lack of neuroinvasiveness for
to four-week-old ICR mice were inoculated ic with 104 PFU/mouse of RP-2ms. We also performed similar experiments in scid
RP-9 or RP-2ms, and two of the mice were sacrificed daily and the (CB-17) mice and similar results were obtained, namely,
brain tissues were then processed as described under Materials and
RP-9 infected brain, but not liver, whereas RP-2ms pri-Methods. The virus titers were determined on BHK-21 cells. RP-9-in-
marily infected liver (data not shown), indicating that thefected mice died at Day 6.
poor neuroinvasiveness of RP-2ms was not due to im-
mune responses of mice. These results combined indi-
and various organs from the infected mice were collected cated that RP-2ms had lower neurovirulence and lower
daily and examined for the presence of viruses. As neuroinvasiveness than RP-9.
shown in Fig. 6A, RP9 was detected in the sera during
the first 2 days of infection, then became undetectable Molecular analysis of the differences in viral
in all the tissues tested for the ensuing 3 days, and finally structural proteins among parental and mutant strains
was detected in the brain on Days 6 and 7. This result
indicated that RP9 was capable of inducing viremia and To determine the possible molecular basis for different
biological properties of these viruses, we studied thecrossing the blood–brain barrier of mice by peripheral
inoculation. In contrast, RP-2ms was not detected in sera viral structural protein genes among these variants.
cDNAs were generated from viral RNA by RT-PCR andthroughout the study (Fig. 6B), indicating that it did not
induce viremia in infected mice. sequenced (see Materials and Methods). Table 2 shows
that, between RP9 and RP2-ms, there are two nucleotideInterestingly, RP2-ms was detected exclusively in liver
tissues; it appeared in liver at Day 2 p.i., peaked at Day differences: one at position 1389, G in RP9 and A in RP2-
ms, which results in an amino acid substitution in E3 p.i., and declined thereafter (Fig. 6B), suggesting viral
FIG. 6. Organ tropism of RP-9 and RP-2ms in the ip-infected mice. Four-week-old female ICR mice were ip infected with 1 1 105 PFU of either
RP-9 or RP-2ms and two of the mice were sacrificed daily for blood and tissue collections. The samples were processed and plaque-assayed on
BHK-21 cells to determine the virus titers in each organ.
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protein at position 138, from Glu in RP-9 to Lys in RP- tional transition between dimer and trimer. In fact, several
single mutations in E proteins of flaviviruses have been2ms. Another nucleotide difference was at position 603,
from T in RP9 to C in RP2-ms, resulting in a substitution proven to be responsible for the viral virulence, whose
locations appeared to be clustered in three regions: theat position 43 of prM protein, from Tyr in RP-9 to His in
RP-2ms (Table 2). The sequence of RP-9 here was identi- distal face of domain III, the base of domain II, and the
junction between domains I and III (reviewed in Rey etcal to that of the wild-type (NT109) virus. The second
mutation was localized within the N-terminal 92 amino al., 1995). Based on the E protein of TBE virus, E-138 of
JEV can be predicted to be located in the external regionacids of prM, which is proteolytically removed from the
mature M protein (7 kDa) in the virions (Chambers et al., of domain I (see above) and close to the junction between
domains I and II, making E-138 a critical amino acid1990). Therefore, in mature mutant virions, there was only
one mutation in the structural proteins of these variants. for E dimer on viral envelope to interact with cellular
molecules. The nature of cellular 57-kDa protein in JEVThese data are in agreement with the in vitro mutagene-
sis data (Sumiyoshi et al., 1995) in that the change of infection remains to be studied; this protein is not likely
to be the viral receptor on BHK-21 cells, because RP-Glu to Lys in JEV E protein at position 138 was tightly
associated with their neurovirulence in mice. These 2ms can readily infect BHK-21 cells despite its failure to
bind to the protein (Fig. 2). It is possible that this 57-kDachanges in E protein, or in conjunction with the prM
mutation, may be responsible, in part, for the differences protein is an accessory molecule on the surface of BHK-
21 cells, which facilitates the interaction between theobserved between the two mutants, RP-9 and RP-2ms,
in growth properties in BHK-21 cells in vitro and neurovi- putative receptor and the JEV E protein during receptor-
mediated endocytosis. The failure of RP-2ms to bind torulence and neuroinvasiveness in mice.
the 57-kDa protein might contribute to the impairment of
virus attachment to BHK-21 cells. Alternatively, RP-2msDISCUSSION
could use an entirely different receptor on BHK-21 cells,
resulting in change of the binding kinetics between theWe have generated two JEV mutants from a local wild-
type virus strain by g-irradiation, which exhibited differ- virus and BHK-21 cells.
Avirulent RP-2ms exhibited small plaques, whereas vir-ent phenotypes both in vitro and in vivo. The mutants
differed in plaque morphology (Fig. 1), growth features ulent RP-9 displayed large plaques (Fig. 1), consistent
with previous observations (Eckels et al., 1988; Sumiy-(Fig. 2), and adsorption characteristics in BHK-21 cells
(Fig. 3). They also differed in neurovirulence (Table 1), oshi et al., 1995), in which the plaque size of JEV variants
correlated with their virulence in mice. Based on ourneuroinvasiveness, and organ tropism in mice (Fig. 6).
In the virus adsorption assay (Fig. 3), RP-9 bound more (Table 2) and others’ results (Sumiyoshi et al., 1995), the
plaque morphology of JEV appears also linked to theefficiently than RP-2ms to BHK-21 cells. RP-9 could satu-
rate the adsorption to BHK-21 cells in 2 hr, whereas RP- single-amino-acid substitution in E protein at residue
138; i.e., Glu was found to be associated with large-2ms required more than 4 hr. Additionally, in the in vitro
binding assay (Fig. 4), RP-9, but not RP-2ms, bound spe- plaque morphology of wild-type NT109 and mutant RP-
9, whereas Lys was associated with small plaques ofcifically to a cellular protein of 57 kDa in BHK-21 cells.
Given that the E protein is the major viral envelope pro- mutant RP-2ms. Conceivably, because of the poor ad-
sorption ability, RP-2ms may limit its spread from onetein of flaviviruses, which interacts with the surface mole-
cules of host cells (Heinz, 1986), any molecular changes cell to another, resulting in its small-plaque phenotype.
Another factor contributing to the small plaque size isin the E protein may account for the differences in the
properties of viral adsorption. Indeed, we detected a sin- inferred from the finding that most of the RP-2ms viruses
were associated with cells and were not released (Fig.gle-amino-acid change in E protein at position 138 (E-
138), from negatively-charged Glu in RP-9 to positively- 2). This property will also limit the spread of the virus to
neighboring cells. Conceivably, this is also the result ofcharged Lys in RP-2ms (Table 2), clearly indicating the
importance of E-138 for JEV infection in BHK-21 cells, the mutation in the E protein (see above), but other pro-
teins, such as NS1 or prM may also be involved, becauseespecially at the stage of virus attachment.
Recently, the structure of E protein of tick-borne en- both the virus secretion pathway and the biosynthesis of
NS1 and prM pass through the same route of ER–Golgicephalitis virus, covering amino acids from 1 to 395, has
been crystallographically determined by Rey et al. (1995). complex in the infected cells (Mason, 1989). Intracellu-
larly, prM plays an important role in virus maturation andThe E monomer folds into three distinct domains: a cen-
tral b-barrel (domain I), an elongated dimerization region release during the late stage of infection (Konishi and
Mason, 1993). During morphogenesis, prM is believed(domain II), and a C-terminal, immunoglobulin-like mod-
ule (domain III). Domain III is proposed to be involved in to prevent acid-induced inactivation of virus, by interac-
tion with E, during transport through acidic compartmentreceptor recognition and domain II is involved in dimer-
ization; domain I, probably together with other domain(s), of the trans-Golgi network (Guirakhoo et al., 1992; Heinz
et al., 1994). Additionally, a single-amino-acid differencemay play a critical role in the pH-mediated conforma-
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Brinton, M. A. (1986). Replication of flaviviruses. In ‘‘The Togaviridaehad also been identified in the NS1 at position 339 be-
and Flaviviridae’’ (S. Schlesinger and M. J. Schlesinger, Eds.), pp.tween these two mutants, from Arg in RP-9 to Gly in RP-
327–374. Plenum, New York.
2ms (data not shown). Although the precise role of NS1 Burke, D. S., and Leake, C. J. (1988). Japanese encephalitis. In ‘‘The
in viral maturation and release is unclear, E–NS1 hetero- Arboviruses: Epidemiology and Ecology’’ (T. Monath, Ed.), Vol. 3, pp.
63–92. CRC Press, Boca Raton, FL.dimers have been detected in JEV-infected cells (Blitvich
Carbone, K. M., Rubin, S. A., Sierra-Honigmann, A. M., and Ledermann,et al., 1995), suggesting that the interaction between the
H. M. (1993). Characterization of a glia cell line persistently infectedtwo viral glycoproteins did exist and might influence the
with borna disease virus (BDV): Influence of neurotrophic factors on
process of viral morphogenesis. Therefore, mutated prM, BDV protein and RNA expression. J. Virol. 67, 1453–1460.
probably together with mutated E as well as NS1 glyco- Cecilia, D., and Gould, E. A. (1991). Nucleotide changes responsible
for loss of neuroinvasiveness in Japanese encephalitis virus neutral-proteins, may account for the cell-associated phenotype
ization-resistant mutants. Virology 181, 70–77.of RP-2ms. Paradoxically, RP-2ms yielded a higher virus
Chamberlain, R. W. (1980). Epidemiology of arthropod-borne togavi-titer than RP-9 despite its smaller plaque size. This
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demic Press, New York.ble for viral replication. The complete sequencing of the
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1). Moreover, when peripherally inoculated, the organ traction. Anal. Biochem. 162, 156–159.
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6, 513–518.
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